Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Interest Expenses (2020 - 2025)

LifeStance Health (LFST) has disclosed Interest Expenses for 6 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 69.4% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 56.05% decrease, with the full-year FY2025 number at $11.7 million, down 56.05% from a year prior.
  • Interest Expenses was $2.9 million for Q4 2025 at LifeStance Health, up from $2.8 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $23.2 million in Q2 2021 to a low of $2.8 million in Q3 2025.
  • A 5-year average of $5.9 million and a median of $5.1 million in 2022 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: skyrocketed 316.65% in 2021, then tumbled 69.4% in 2025.
  • LifeStance Health's Interest Expenses stood at $3.6 million in 2021, then soared by 43.39% to $5.2 million in 2022, then rose by 7.11% to $5.5 million in 2023, then surged by 69.85% to $9.4 million in 2024, then crashed by 69.4% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Interest Expenses are $2.9 million (Q4 2025), $2.8 million (Q3 2025), and $2.9 million (Q2 2025).